Clinicopathologic and proteomic characteristics of intratubular cytoplasmic AL amyloidosis

Affiliations

• ¹ Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Nephrology, Centre Hospitalier Universitaire, Université de Poitiers, Poitiers, France. Electronic address: javaugue.vincent@yahoo.fr.
• ² Arkana Laboratories, Little Rock, Arkansas, USA.
• ³ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
• ⁴ Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA.
• ⁵ Department of Pathology, Cedars Sinai Medical Center, Los Angeles, California, USA.
• ⁶ Department of Qualitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
• ⁷ Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA; Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
• ⁸ Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: nasr.samih@mayo.edu.